Collectively, participants from the disease groups (i.e., GBS, CBDS, SCBD) displayed poor liver situations when compared to those of HCs, indicated by higher total bilirubin (TBIL), alanine transaminase (ALT), aspartate transaminase (AST), or alkaline phosphatase (ALP) indexes (Kruskal–Wallis test, p ≤ 0.05) (Table 1). The gene discussed is GPT; the disease is Guillain-Barre syndrome.